{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:23:36Z","timestamp":1785493416431,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inflammation has a major role in the pathogenesis of heart failure (HF). It triggers a cascade that leads to the release of pro-inflammatory cytokines which in turn cause cardiac hypertrophy, fibrosis, apoptosis, negative inotorpy and leukocyte recruitment which worsen the condition. Neopterin is an inflammatory biomarker which is released as a response to macrophage activation. Levels of neopterin are elevated in conditions which has an immunological component such as autoimmune disease, viral and bacterial infections and malignancy. Neopterin levels were found to be elevated in patients with HF. This is due to the fact that inflammation takes place during the development of the condition. Studies demonstrated that neopterin can be used as a biomarker for diagnosing HF, determining severity of the disease and monitoring its progression. Neopterin levels were higher in patients with New York Heart Association classification (NYHA) III\u2013IV more than class I\u2013II. Moreover, neopterin levels correlated well with morbidity and mortality. It has been suggested that neopterin be monitored levels to determine effectiveness of HF treatment options.<\/jats:p>\n                <jats:p><jats:bold>Graphical abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s10787-022-01028-5","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T13:03:21Z","timestamp":1658754201000},"page":"1617-1622","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Role of neopterin as an inflammatory biomarker in congestive heart failure with insights on effect of drug therapies on its level"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2505-0915","authenticated-orcid":false,"given":"Gaidaa M.","family":"Dogheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed T.","family":"Amralla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5983-3993","authenticated-orcid":false,"given":"Rehab H.","family":"Werida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,25]]},"reference":[{"issue":"5","key":"1028_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","volume":"17","author":"L Adamo","year":"2020","unstructured":"Adamo L, Rocha-Resende C, Prabhu SD, Mann DL (2020) Reappraising the role of inflammation in heart failure. Nat Rev Cardiol. 17(5):269\u2013285. https:\/\/doi.org\/10.1038\/s41569-019-0315-x","journal-title":"Nat Rev Cardiol."},{"issue":"5","key":"1028_CR2","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.amjcard.2003.11.035","volume":"93","author":"P Avanzas","year":"2004","unstructured":"Avanzas P, Arroyo-Espliguero R, Cosin-Sales J, Quiles J, Zouridakis E, Kaski JC (2004) Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease. Am J Cardiol 93(5):627\u2013629","journal-title":"Am J Cardiol"},{"issue":"5","key":"1028_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/eurheartj\/ehi111","volume":"26","author":"P Avanzas","year":"2005","unstructured":"Avanzas P, Arroyo-Espliguero R, Quiles J, Roy D, Kaski JC (2005) Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J 26(5):457\u2013463. https:\/\/doi.org\/10.1093\/eurheartj\/ehi111","journal-title":"Eur Heart J"},{"issue":"3","key":"1028_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ejheart.2004.01.008","volume":"6","author":"P Bettencourt","year":"2004","unstructured":"Bettencourt P (2004) NT-proBNP and BNP: biomarkers for heart failure management. Eur J Heart Fail 6(3):359\u2013363. https:\/\/doi.org\/10.1016\/j.ejheart.2004.01.008","journal-title":"Eur J Heart Fail"},{"issue":"1\u20132","key":"1028_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.clinbiochem.2012.10.022","volume":"46","author":"R Caruso","year":"2013","unstructured":"Caruso R, De Chiara B, Campolo J et al (2013) Neopterin levels are independently associated with cardiac remodeling in patients with chronic heart failure. Clin Biochem 46(1\u20132):94\u201398. https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.10.022","journal-title":"Clin Biochem"},{"key":"1028_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11886-020-01382-2","volume":"22","author":"EC Castillo","year":"2020","unstructured":"Castillo EC, V\u00e1zquez-Garza E, Yee-Trejo D et al (2020) What is the role of the inflammation in the pathogenesis of heart failure? Curr Cardiol Rep 22:139. https:\/\/doi.org\/10.1007\/s11886-020-01382-2","journal-title":"Curr Cardiol Rep"},{"issue":"7","key":"1028_CR7","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1056\/NEJM199608153350707","volume":"335","author":"JN Cohn","year":"1996","unstructured":"Cohn JN (1996) The management of chronic heart failure. N Engl J Med 335(7):490\u2013498. https:\/\/doi.org\/10.1056\/NEJM199608153350707","journal-title":"N Engl J Med"},{"issue":"3","key":"1028_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/00015385.2018.1478266","volume":"74","author":"\u015e Demir","year":"2019","unstructured":"Demir \u015e, Ede H, Kaplan M, Yavuz F, Y\u00fccel C, Kurt \u0130H (2019) Neopterin as a novel marker; well correlated with mortality and morbidity in patients with advanced systolic heart failure. Acta Cardiol 74(3):216\u2013221. https:\/\/doi.org\/10.1080\/00015385.2018.1478266","journal-title":"Acta Cardiol"},{"issue":"1","key":"1028_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","volume":"119","author":"SA Dick","year":"2016","unstructured":"Dick SA, Epelman S (2016) Chronic heart failure and inflammation: what do we really know? Circ Res 119(1):159\u2013176. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308030","journal-title":"Circ Res"},{"issue":"6","key":"1028_CR10","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00228-022-03290-6","volume":"78","author":"GM Dogheim","year":"2022","unstructured":"Dogheim GM, Khairat I, Omran GA, El-Haggar SM, Amrawy AME, Werida RH (2022) Clinical comparative study assessing the effect of ivabradine on neopterin and NT-Pro BNP against standard treatment in chronic heart failure patients. Eur J Clin Pharmacol 78(6):943\u2013954. https:\/\/doi.org\/10.1007\/s00228-022-03290-6","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"1028_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ijcard.2005.11.024","volume":"111","author":"A Dominguez-Rodriguez","year":"2006","unstructured":"Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez M (2006) Usefulness of neopterin levels and left ventricular function for risk assessment in survivors of acute myocardial infarction. Int J Cardiol 111(2):318\u2013320. https:\/\/doi.org\/10.1016\/j.ijcard.2005.11.024","journal-title":"Int J Cardiol"},{"issue":"10","key":"1028_CR12","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1161\/01.atv.19.10.2355","volume":"19","author":"M Erren","year":"1999","unstructured":"Erren M, Reinecke H, Junker R et al (1999) Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 19(10):2355\u20132363. https:\/\/doi.org\/10.1161\/01.atv.19.10.2355","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3\u20134","key":"1028_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3109\/10408369209114604","volume":"29","author":"D Fuchs","year":"1992","unstructured":"Fuchs D, Weiss G, Reibnegger G, Wachter H (1992) The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 29(3\u20134):307\u2013341. https:\/\/doi.org\/10.3109\/10408369209114604","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"7","key":"1028_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/antiox7070080","volume":"7","author":"SP Gieseg","year":"2018","unstructured":"Gieseg SP, Baxter-Parker G, Lindsay A (2018) Neopterin, inflammation, and oxidative stress: what could we be missing? Antioxidants (Basel) 7(7):80. https:\/\/doi.org\/10.3390\/antiox7070080","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"1028_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1600-0625.1999.tb00367.x","volume":"8","author":"FF Hamerlinck","year":"1999","unstructured":"Hamerlinck FF (1999) Neopterin: a review. Exp Dermatol 8(3):167\u2013176. https:\/\/doi.org\/10.1111\/j.1600-0625.1999.tb00367.x","journal-title":"Exp Dermatol"},{"issue":"5","key":"1028_CR16","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/CIRCRESAHA.118.312706","volume":"123","author":"NE Ibrahim","year":"2018","unstructured":"Ibrahim NE, Januzzi JL Jr (2018) Established and emerging roles of biomarkers in heart failure. Circ Res 123(5):614\u2013629. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.312706","journal-title":"Circ Res"},{"issue":"12","key":"1028_CR17","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nrd1901","volume":"4","author":"MK Jain","year":"2005","unstructured":"Jain MK, Ridker PM (2005) Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 4(12):977\u2013987. https:\/\/doi.org\/10.1038\/nrd1901","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"1028_CR18","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1373\/clinchem.2005.054171","volume":"51","author":"JC Kaski","year":"2005","unstructured":"Kaski JC, Avanzas P, Arroyo-Espliguero R (2005) Neopterin: still a forgotten biomarker. Clin Chem 51(10):1902\u20131903. https:\/\/doi.org\/10.1373\/clinchem.2005.054171","journal-title":"Clin Chem"},{"issue":"5","key":"1028_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.carpath.2011.11.007","volume":"21","author":"CD Kemp","year":"2012","unstructured":"Kemp CD, Conte JV (2012) The pathophysiology of heart failure. Cardiovasc Pathol 21(5):365\u2013371. https:\/\/doi.org\/10.1016\/j.carpath.2011.11.007","journal-title":"Cardiovasc Pathol"},{"issue":"18","key":"1028_CR20","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.110.979500","volume":"123","author":"HN Kim","year":"2011","unstructured":"Kim HN, Januzzi JL Jr (2011) Natriuretic peptide testing in heart failure. Circulation 123(18):2015\u20132019. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.979500","journal-title":"Circulation"},{"issue":"12","key":"1028_CR21","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.3390\/jcm8122230","volume":"8","author":"L Lanser","year":"2019","unstructured":"Lanser L, P\u00f6lzl G, Fuchs D, Weiss G, Kurz K (2019) Neopterin is associated with disease severity and outcome in patients with non-ischaemic heart failure. J Clin Med 8(12):2230. https:\/\/doi.org\/10.3390\/jcm8122230","journal-title":"J Clin Med"},{"issue":"17","key":"1028_CR22","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","volume":"72","author":"P Libby","year":"2018","unstructured":"Libby P, Loscalzo J, Ridker PM et al (2018) Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week. J Am Coll Cardiol 72(17):2071\u20132081. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.1043","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1028_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ejheart.2004.01.010","volume":"6","author":"TA McDonagh","year":"2004","unstructured":"McDonagh TA, Holmer S, Raymond I, Luchner A, Hildebrant P, Dargie HJ (2004) NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail 6(3):269\u2013273. https:\/\/doi.org\/10.1016\/j.ejheart.2004.01.010","journal-title":"Eur J Heart Fail"},{"issue":"36","key":"1028_CR24","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M et al (2021) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure [published correction appears in Eur Heart. J. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"J. Eur Heart J"},{"issue":"3","key":"1028_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2165\/11592090-000000000-00000","volume":"11","author":"RP Morrissey","year":"2011","unstructured":"Morrissey RP, Czer L, Shah PK (2011) Chronic heart failure: current evidence, challenges to therapy, and future directions. Am J Cardiovasc Drugs 11(3):153\u2013171. https:\/\/doi.org\/10.2165\/11592090-000000000-00000","journal-title":"Am J Cardiovasc Drugs"},{"issue":"6 Pt 1","key":"1028_CR26","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/s0002-8703(99)70079-7","volume":"138","author":"DR Murdoch","year":"1999","unstructured":"Murdoch DR, McDonagh TA, Byrne J et al (1999) Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J 138(6 Pt 1):1126\u20131132. https:\/\/doi.org\/10.1016\/s0002-8703(99)70079-7","journal-title":"Am Heart J"},{"issue":"11","key":"1028_CR27","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","volume":"75","author":"SP Murphy","year":"2020","unstructured":"Murphy SP, Kakkar R, McCarthy CP, Januzzi JL Jr (2020) Inflammation in heart failure: JACC state-of-the-art review. J Am Coll Cardiol 75(11):1324\u20131340. https:\/\/doi.org\/10.1016\/j.jacc.2020.01.014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1028_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2174\/1389200024605082","volume":"3","author":"C Murr","year":"2002","unstructured":"Murr C, Widner B, Wirleitner B, Fuchs D (2002) Neopterin as a marker for immune system activation. Curr Drug Metab 3(2):175\u2013187. https:\/\/doi.org\/10.2174\/1389200024605082","journal-title":"Curr Drug Metab"},{"issue":"3","key":"1028_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4103\/0019-5278.44690","volume":"12","author":"SK Pingle","year":"2008","unstructured":"Pingle SK, Tumane RG, Jawade AA (2008) Neopterin: Biomarker of cell-mediated immunity and potent usage as biomarker in silicosis and other occupational diseases. Indian J Occup Environ Med 12(3):107\u2013111. https:\/\/doi.org\/10.4103\/0019-5278.44690","journal-title":"Indian J Occup Environ Med"},{"issue":"2","key":"1028_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4065\/mcp.2009.0494","volume":"85","author":"GV Ramani","year":"2010","unstructured":"Ramani GV, Uber PA, Mehra MR (2010) Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc 85(2):180\u2013195. https:\/\/doi.org\/10.4065\/mcp.2009.0494","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"1028_CR31","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1532-5415.1997.tb02968.x","volume":"45","author":"MW Rich","year":"1997","unstructured":"Rich MW (1997) Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 45(8):968\u2013974. https:\/\/doi.org\/10.1111\/j.1532-5415.1997.tb02968.x","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"1028_CR32","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/s0735-1097(97)00172-1","volume":"30","author":"M Schumacher","year":"1997","unstructured":"Schumacher M, Halwachs G, Tatzber F et al (1997) Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol 30(3):703\u2013707. https:\/\/doi.org\/10.1016\/s0735-1097(97)00172-1","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1028_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ejheart.2003.12.009","volume":"6","author":"Y Seino","year":"2004","unstructured":"Seino Y, Ogawa A, Yamashita T et al (2004) Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail 6(3):295\u2013300. https:\/\/doi.org\/10.1016\/j.ejheart.2003.12.009","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"1028_CR34","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/j.amjcard.2014.03.016","volume":"113","author":"Z Shao","year":"2014","unstructured":"Shao Z, Zhang R, Shrestha K et al (2014) Usefulness of elevated urine neopterin levels in assessing cardiac dysfunction and exercise ventilation inefficiency in patients with chronic systolic heart failure. Am J Cardiol 113(11):1839\u20131843. https:\/\/doi.org\/10.1016\/j.amjcard.2014.03.016","journal-title":"Am J Cardiol"},{"issue":"6","key":"1028_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11883-017-0660-3","volume":"19","author":"LF Shirazi","year":"2017","unstructured":"Shirazi LF, Bissett J, Romeo F, Mehta JL (2017) Role of inflammation in heart failure. Curr Atheroscler Rep 19(6):27. https:\/\/doi.org\/10.1007\/s11883-017-0660-3","journal-title":"Curr Atheroscler Rep"},{"issue":"5 Suppl 3","key":"1028_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1527-5299.2004.03271.x","volume":"10","author":"MA Silver","year":"2004","unstructured":"Silver MA, Maisel A, Yancy CW et al (2004) BNP consensus panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail 10(5 Suppl 3):1\u201330. https:\/\/doi.org\/10.1111\/j.1527-5299.2004.03271.x","journal-title":"Congest Heart Fail"},{"issue":"7","key":"1028_CR37","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/0735-1097(93)90776-w","volume":"22","author":"CJ Wiedermann","year":"1993","unstructured":"Wiedermann CJ, Beimpold H, Herold M, Knapp E, Braunsteiner H (1993) Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha. J Am Coll Cardiol 22(7):1897\u20131901. https:\/\/doi.org\/10.1016\/0735-1097(93)90776-w","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1028_CR38","first-page":"CR232","volume":"16","author":"I Wietlicka-Kokoszanek","year":"2010","unstructured":"Wietlicka-Kokoszanek I, Jablecka A, Smolarek I et al (2010) Neopterin as a prognostic marker in patients with chronic heart failure. Med Sci Monit 16(5):CR232\u2013CR237","journal-title":"Med Sci Monit"},{"issue":"1","key":"1028_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/ehf2.12070","volume":"3","author":"E Yamamoto","year":"2016","unstructured":"Yamamoto E, Hirata Y, Tokitsu T et al (2016) The clinical significance of plasma neopterin in heart failure with preserved left ventricular ejection fraction. ESC Heart Fail 3(1):53\u201359. https:\/\/doi.org\/10.1002\/ehf2.12070","journal-title":"ESC Heart Fail"},{"issue":"13","key":"1028_CR40","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1161\/01.CIR.0000142664.18739.92","volume":"110","author":"E Zouridakis","year":"2004","unstructured":"Zouridakis E, Avanzas P, Arroyo-Espliguero R, Fredericks S, Kaski JC (2004) Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 110(13):1747\u20131753. https:\/\/doi.org\/10.1161\/01.CIR.0000142664.18739.92","journal-title":"Circulation"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01028-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-022-01028-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01028-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T11:24:00Z","timestamp":1663845840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-022-01028-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,25]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1028"],"URL":"https:\/\/doi.org\/10.1007\/s10787-022-01028-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,25]]},"assertion":[{"value":"14 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of of interest"}}]}}